Are there laboratory tests to detect Systemic Lupus Erythematosus (SLE) flare markers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, there are several blood tests that can help detect a lupus flare, including anti-dsDNA antibodies, complement levels, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), as recommended by the European League Against Rheumatism 1. The most common markers used to monitor lupus activity include:

  • Anti-dsDNA antibodies, which often rise during active disease
  • Complement levels (C3 and C4), which typically decrease during flares
  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), both of which increase with inflammation
  • Complete blood count (CBC) to show decreases in white blood cells, red blood cells, or platelets during flares
  • Urinalysis to reveal protein or blood in urine if kidneys are affected These tests are usually ordered together as part of regular monitoring for lupus patients. According to the European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies 1, laboratory assessment, including changes in anti-double-stranded (ds) DNA antibody titres, complement levels, and other markers, can be useful in monitoring disease activity. However, laboratory markers don't always correlate perfectly with symptoms, so doctors consider both lab results and clinical symptoms when determining if a flare is occurring. Regular monitoring every 3-6 months is recommended for stable patients, with more frequent testing during suspected flares, as suggested by the EULAR recommendations for the management of systemic lupus erythematosus 1. It's also important to note that the assessment of patients with SLE must include the evaluation of disease activity by a validated index at each visit, organ damage annually, general quality of life, comorbidities, and drug toxicity, as recommended by the European League Against Rheumatism 1.

From the Research

Testing Markers for Lupus Flare

To determine if a lupus flare is occurring, several markers can be tested, including:

  • Erythrocyte sedimentation rate (ESR)
  • C-reactive protein (CRP)
  • The ratio of ESR to CRP

ESR and CRP Levels

Studies have shown that:

  • ESR levels can be elevated in both lupus flares and infections, making it difficult to distinguish between the two conditions 2, 3, 4
  • CRP levels tend to be lower in lupus flares compared to infections, but can still be elevated in some cases 2, 3, 4, 5
  • A high-sensitivity CRP (hsCRP) test can help distinguish between infection and lupus flare, with a cut-off value of above 5-6 mg/dl indicating infection 4

Ratio of ESR to CRP

Research has found that:

  • The ratio of ESR to CRP can be useful in distinguishing between lupus flare and infection, with a higher ratio indicating a lupus flare 2
  • Each unit increase in the ratio of ESR:CRP was associated with a 17% increase in the odds of fever being attributable to SLE flare compared to infection 2

Clinical Application

In clinical practice, measuring ESR, CRP, and the ratio of ESR to CRP can help healthcare providers:

  • Monitor disease activity and distinguish between lupus flare and infection
  • Adjust treatment plans accordingly
  • Improve patient outcomes by reducing disease exacerbations and organ damage 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.